Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
Hims & Hers Health (NYSE: HIMS) announced two key leadership appointments to strengthen its quality and safety standards. Deb Autor, former FDA deputy commissioner, joins the board of directors, bringing over 30 years of pharmaceutical and regulatory experience. Janet Stevens, a pharmaceutical quality expert previously with Hillrom and Pfizer, joins as Global Head of Quality & Safety. Both appointments reinforce the company's commitment to clinical excellence and safety across its health and wellness platform.
Hims & Hers Health (NYSE: HIMS) ha annunciato due importanti nomine nel suo team dirigenziale per rafforzare gli standard di qualità e sicurezza. Deb Autor, ex vice commissario della FDA, entra a far parte del consiglio di amministrazione, portando con sé oltre 30 anni di esperienza nel settore farmaceutico e normativo. Janet Stevens, esperta di qualità farmaceutica precedentemente in Hillrom e Pfizer, si unisce come Responsabile Globale di Qualità e Sicurezza. Entrambe le nomine rafforzano l'impegno dell'azienda verso l'eccellenza clinica e la sicurezza all'interno della sua piattaforma di salute e benessere.
Hims & Hers Health (NYSE: HIMS) anunció dos nombramientos clave en su liderazgo para fortalecer sus estándares de calidad y seguridad. Deb Autor, exvicecomisionada de la FDA, se une a la junta directiva, aportando más de 30 años de experiencia en el sector farmacéutico y regulatorio. Janet Stevens, experta en calidad farmacéutica que anteriormente trabajó en Hillrom y Pfizer, asumirá el cargo de Jefa Global de Calidad y Seguridad. Ambos nombramientos refuerzan el compromiso de la empresa con la excelencia clínica y la seguridad en su plataforma de salud y bienestar.
Hims & Hers Health (NYSE: HIMS)는 품질 및 안전 기준을 강화하기 위해 두 가지 주요 리더십 임명을 발표했습니다. Deb Autor, 전 FDA 부국장이 이사회에 합류하여 30년 이상의 제약 및 규제 경험을 제공합니다. Janet Stevens, 이전에 Hillrom과 Pfizer에서 근무했던 제약 품질 전문가가 글로벌 품질 및 안전 책임자로 합류합니다. 두 임명 모두 회사의 임상 우수성과 건강 및 웰빙 플랫폼에서의 안전성을 강화하는 데 기여하고 있습니다.
Hims & Hers Health (NYSE: HIMS) a annoncé deux nominations clés au sein de sa direction pour renforcer ses normes de qualité et de sécurité. Deb Autor, ancienne commissaire adjointe de la FDA, rejoint le conseil d'administration, apportant plus de 30 ans d'expérience dans le secteur pharmaceutique et réglementaire. Janet Stevens, experte en qualité pharmaceutique précédemment chez Hillrom et Pfizer, rejoint l'entreprise en tant que Responsable Mondiale de la Qualité et de la Sécurité. Ces deux nominations renforcent l'engagement de l'entreprise envers l'excellence clinique et la sécurité au sein de sa plateforme de santé et de bien-être.
Hims & Hers Health (NYSE: HIMS) gab die Ernennung von zwei wichtigen Führungskräften bekannt, um die Qualitäts- und Sicherheitsstandards zu stärken. Deb Autor, ehemalige stellvertretende Kommissarin der FDA, tritt dem Vorstand bei und bringt über 30 Jahre Erfahrung in der Pharma- und Regulierungsbranche mit. Janet Stevens, eine Expertin für pharmazeutische Qualität, die zuvor bei Hillrom und Pfizer tätig war, wird zur Global Head of Quality & Safety ernannt. Beide Ernennungen bekräftigen das Engagement des Unternehmens für klinische Exzellenz und Sicherheit auf seiner Gesundheits- und Wellness-Plattform.
- Strengthened leadership team with high-profile pharmaceutical and regulatory experts
- Addition of former FDA deputy commissioner adds valuable regulatory expertise
- Appointment of experienced quality executive from Pfizer and Hillrom enhances quality control
- None.
Former FDA deputy commissioner and former Pfizer & Hillrom quality executive join Hims & Hers, deepening the leadership that drives the company’s high standard of quality and safety
Former FDA deputy commissioner and former Pfizer & Hillrom quality executive join Hims & Hers, deepening the leadership that drives the company’s high standard of quality and safety. (Photo: Business Wire)
Autor brings more than 30 years of experience across pharmaceutical quality and compliance, regulatory programs, and consumer protection to Hims & Hers. She previously served as the Deputy Commissioner for Global Regulatory Operations and Policy at the FDA, where she oversaw FDA inspections, criminal investigations, and international operations for the agency. She also served as the agency’s Director of the Office of Compliance for the Center for Drug Evaluation and Research, leading enforcement for drug requirements. As a trial attorney for the Department of Justice, the FDA was her primary client. She has also served as the Global Head of Regulatory Excellence at AstraZeneca and is currently the CEO of Healthcare Innovation Catalysts.
Stevens has spent her entire career in pharmaceutical quality assurance, operations, and engineering. She joins Hims & Hers from Hillrom, where she served as the Chief Quality Officer, helping the company achieve top-quartile results in global quality regulations. She also served as Pfizer’s Vice President of Sterile Injectable Quality Operations, where she led the company’s quality organizations and enabled successful regulatory inspections globally with regulatory authorities like the FDA, MHRA, and Health Canada.
“We’ve built a customer experience that prioritizes clinical excellence and the highest standard of safety and quality for every person who trusts us with their journey,” said Andrew Dudum, CEO and co-founder of Hims & Hers. “The depth of expertise Deb and Janet bring to the team is incredibly valuable as we continue to scale our operations to meet the needs of the growing number of customers who come to our platform seeking healthcare solutions that fit their individual needs.”
“Affordable, accessible, convenient healthcare for US consumers is lacking, and Hims & Hers is addressing that need,” said Deb Autor. “In my many decades in the healthcare field, this is the first company I’ve seen achieving scale, impact, and quality while pushing innovation in the service of patients. This is an exciting moment and I’m thrilled to be part of it.”
“Customers put an immense amount of trust in healthcare companies, and Hims & Hers is one of the few companies doing the meaningful work to earn that trust,” said Janet Stevens. “The safety of our operations is the foundation of connection we have with our customers. Continuing to strengthen that connection will be a critical part of impacting more lives on our platform.”
Autor joins health and pharmaceutical industry experts on the Hims & Hers Board of Directors including: former Novo Nordisk executive, Kåre Schultz; former CEO of the Cleveland Clinic, Dr. Toby Cosgrove; US regulatory and foreign policy expert, Anja Manuel; and former Chief Medical Officer of Walgreens and current Chief Medical Officer of Hims & Hers, Patrick Carroll, amongst others.
About Hims & Hers Health, Inc.
Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalized care designed for results. For more information, please visit www.hims.com and www.forhers.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241118954274/en/
Press Contact
Abby Reisinger
press@forhims.com
Source: Hims & Hers
FAQ
Who are the new appointments at Hims & Hers (HIMS) in 2024?
What experience does Deb Autor bring to Hims & Hers (HIMS)?
What is Janet Stevens' background before joining Hims & Hers (HIMS)?
